biperiden has been researched along with Neuroleptic Malignant Syndrome in 11 studies
Biperiden: A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
biperiden : A member of the class of piperidines that is N-propylpiperidine in which the methyl hydrogens have been replaced by hydroxy, phenyl, and 5-norbornen-2-yl groups. A muscarinic antagonist affecting both the central and peripheral nervous systems, it is used in the treatment of all forms of Parkinson's disease.
Neuroleptic Malignant Syndrome: A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)
| Excerpt | Relevance | Reference |
|---|---|---|
| "This report describes a case of neuroleptic malignant syndrome due to risperidone in a child with Joubert syndrome." | 5.35 | Neuroleptic malignant syndrome due to risperidone treatment in a child with Joubert syndrome. ( Akin, R; Altun, D; Congologlu, A; Unay, B; Vurucu, S, 2009) |
| "We describe a case of neuroleptic malignant syndrome (NMS) associated with the use of ziprasidone." | 5.34 | Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment. ( Cansel, N; Herken, H; Ozen, ME; Savas, HA; Yumru, M, 2007) |
| "In a schizophrenic patient, hypothermia was caused by combined treatment with zotepine, biperiden, and fluphenazine, although combined treatment with zotepine and biperiden had caused no side effects." | 3.67 | Hypothermia caused by antipsychotic drugs in a schizophrenic patient. ( Hashimoto, H; Kamimura, H; Nakajima, T; Nakao, J; Noto, T; Okamoto, K; Sugae, S, 1987) |
| "This report describes a case of neuroleptic malignant syndrome due to risperidone in a child with Joubert syndrome." | 1.35 | Neuroleptic malignant syndrome due to risperidone treatment in a child with Joubert syndrome. ( Akin, R; Altun, D; Congologlu, A; Unay, B; Vurucu, S, 2009) |
| "We describe a case of neuroleptic malignant syndrome (NMS) associated with the use of ziprasidone." | 1.34 | Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment. ( Cansel, N; Herken, H; Ozen, ME; Savas, HA; Yumru, M, 2007) |
| "As the neuroleptic malignant syndrome ist rare many cases should be collected in order to enhance the knowledge of the etiology and the pathogenesis of that life--threatening complication of treatment with neuroleptic drugs." | 1.28 | [Neuroleptic malignant syndrome--a case report on diagnosis, differential diagnosis and therapy of a life threatening complication of treatment with neuroleptics]. ( Pflug, B; Staud, L, 1992) |
| "A case is reported, in which fatal pulmonary embolism complicated the course of a neuroleptic malignant syndrome (NMS)." | 1.28 | [Malignant neuroleptic syndrome: complete anticoagulant treatment or not?]. ( van Agtmael, MA; van Harten, PN, 1992) |
| "The authors describe a case report of catatonia syndrome after administration of depot neuroleptics." | 1.28 | Neuroleptic-induced catatonia: neuroleptic malignant syndrome? ( Alonso-Abolafia, A; de la Serna, I; de Leon, J; Munoz-Ruata, J; Pico-Soler, E; Saiz-Ruiz, J, 1990) |
| "The dominant symptom was deep coma." | 1.27 | Neuroleptic malignant syndrome: observations on altered consciousness. ( Deuschl, G; Hermle, L; Kindt, H; Oepen, G, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Escobar-Vidarte, MF | 1 |
| Loaiza-Osorio, S | 1 |
| Messa, AA | 1 |
| Macías, GE | 1 |
| Vurucu, S | 1 |
| Congologlu, A | 1 |
| Altun, D | 1 |
| Unay, B | 1 |
| Akin, R | 1 |
| Ozen, ME | 1 |
| Yumru, M | 1 |
| Savas, HA | 1 |
| Cansel, N | 1 |
| Herken, H | 1 |
| Yoshida, K | 1 |
| Takahashi, H | 1 |
| Sato, K | 1 |
| Higuchi, H | 1 |
| Shimizu, T | 1 |
| Staud, L | 1 |
| Pflug, B | 1 |
| van Agtmael, MA | 1 |
| van Harten, PN | 1 |
| de Leon, J | 1 |
| Saiz-Ruiz, J | 1 |
| Alonso-Abolafia, A | 1 |
| Pico-Soler, E | 1 |
| Munoz-Ruata, J | 1 |
| de la Serna, I | 1 |
| Usandizaga, I | 1 |
| Pérez de Mendiola, MM | 1 |
| Buades, J | 1 |
| Martínez, J | 1 |
| Deuschl, G | 1 |
| Oepen, G | 1 |
| Hermle, L | 1 |
| Kindt, H | 1 |
| Noto, T | 1 |
| Hashimoto, H | 1 |
| Sugae, S | 1 |
| Okamoto, K | 1 |
| Nakao, J | 1 |
| Kamimura, H | 1 |
| Nakajima, T | 1 |
| Capellà Hereu, D | 1 |
| Cabeza Gutés, D | 1 |
| Laporte Roselló, JR | 1 |
1 review available for biperiden and Neuroleptic Malignant Syndrome
| Article | Year |
|---|---|
Neuroleptic malignant syndrome in pregnancy: case report and literature review.
Topics: Anticonvulsants; Antipsychotic Agents; Biperiden; Female; Humans; Levetiracetam; Neuroleptic Maligna | 2019 |
10 other studies available for biperiden and Neuroleptic Malignant Syndrome
| Article | Year |
|---|---|
Neuroleptic malignant syndrome due to risperidone treatment in a child with Joubert syndrome.
Topics: Abnormalities, Multiple; Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Antipsychotic Agents; | 2009 |
Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
Topics: Adult; Antipsychotic Agents; Biperiden; Diagnosis, Differential; Diazepam; Drug Therapy, Combination | 2007 |
Biperiden hydrochlorate ameliorates dystonia of rats produced by microinjection of sigma ligands into the red nucleus.
Topics: Animals; Anti-Dyskinesia Agents; Anticonvulsants; Biperiden; Disease Models, Animal; Guanidines; Hal | 2000 |
[Neuroleptic malignant syndrome--a case report on diagnosis, differential diagnosis and therapy of a life threatening complication of treatment with neuroleptics].
Topics: Adult; Antipsychotic Agents; Benperidol; Biperiden; Delayed-Action Preparations; Humans; Male; Neuro | 1992 |
[Malignant neuroleptic syndrome: complete anticoagulant treatment or not?].
Topics: Adult; Anticoagulants; Biperiden; Depressive Disorder; Drug Therapy, Combination; Haloperidol; Human | 1992 |
Neuroleptic-induced catatonia: neuroleptic malignant syndrome?
Topics: Adult; Antipsychotic Agents; Biperiden; Catatonia; Delayed-Action Preparations; Diagnosis, Different | 1990 |
[Neuroleptic malignant syndrome].
Topics: Adult; Biperiden; Chlormethiazole; Chlorpromazine; Dantrolene; Diazepam; Female; Haloperidol; Humans | 1990 |
Neuroleptic malignant syndrome: observations on altered consciousness.
Topics: Adult; Biperiden; Brain; Cholinergic Fibers; Coma; Fever; Humans; Male; Neuroleptic Malignant Syndro | 1987 |
Hypothermia caused by antipsychotic drugs in a schizophrenic patient.
Topics: Adult; Biperiden; Dibenzothiepins; Drug Therapy, Combination; Fluphenazine; Humans; Hypothermia; Mal | 1987 |
[Malignant neuroleptic syndrome and biperiden].
Topics: Biperiden; Haloperidol; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Piperidines | 1985 |